Food and Drug Administration, HHS.
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for emergency processing under the Paperwork Reduction Act of 1995 (the PRA). The proposed collection of information will be used by FDA to determine whether reprocessed single-use devices (SUDs) are substantially equivalent to legally marketed predicate devices. FDA is requesting this emergency processing under the PRA to implement the statutory provision under section 302 of the Medical Device User Fee and Modernization Act of 2002 (MDUFMA).
Submit comments on the collection of information by August 7, Start Printed Page 406772003. FDA is requesting approval of this emergency processing by August 22, 2003.
OMB is still experiencing significant delays in the regular mail, including first class and express mail, and messenger deliveries are not being accepted. To ensure that comments on the information collection are received, OMB recommends that written comments be electronically mailed to email@example.com or faxed to the Office of Information and Regulatory Affairs, OMB, Attn: Stuart Shapiro, Desk Officer for FDA, FAX: 202-395-6974. All comments should be identified with the docket number found in brackets in the heading of this document.Start Further Info
FOR FURTHER INFORMATION CONTACT:
Peggy Robbins, Office of Information Resources Management (HFA-250), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1223.End Further Info End Preamble Start Supplemental Information
FDA has requested emergency processing of this proposed collection of information under section 3507(j) of the PRA (44 U.S.C. 3507(j) and 5 CFR 1320.13). This information is needed immediately so that the agency can provide guidance to implement the statutory provision under section 302 of MDUFMA requiring manufacturers to submit validation data for certain reprocessed SUDs. Under section 302 of MDUFMA, FDA was required to publish a list of reprocessed SUDs currently subject to premarket notification requirements for which validation data are necessary, as well as a list of reprocessed SUDs for which an existing exemption from premarket notification requirements will no longer apply. Manufacturers of reprocessed SUDs included in these lists are required by MDUFMA to submit validation data (through the appropriate mechanism) within timeframes specified in the statute.
MDUFMA was signed into law on October 26, 2002. The use of normal clearance procedures would likely result in the prevention or disruption of this collection of information. Therefore, FDA has requested approval of this emergency processing of this proposed collection of information by (see DATES).
FDA invites comments on: (1) Whether the proposed collection of information is necessary for the proper performance of FDA's functions, including whether the information will have practical utility; (2) the accuracy of FDA's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques, when appropriate, and other forms of information technology.
Submission of Validation Data for Reprocessed Single Use Devices
Section 302(b) of MDUFMA adds new requirements for reprocessed SUDs to section 510 of the Food Drug and Cosmetic Act (the act) (21 U.S.C. 360)). One of MDUFMA's provisions requires the submission of validation data specified in the statute for certain reprocessed SUDs (as identified by FDA). The types of validation data include cleaning and sterilization data and functional performance data.
MDUFMA requires that FDA review the types of reprocessed SUDs now subject to premarket notification requirements and identify which of these devices require the submission of validation data to ensure their substantial equivalence to predicate devices. MDUFMA also requires that FDA review critical and semi-critical reprocessed SUDs that are currently exempt from premarket notification requirements and determine which of these devices require the submission of 510(k)s to ensure their substantial equivalence to predicate devices. Under MDUFMA, the validation data submitted for a reprocessed SUD must demonstrate that the device will remain substantially equivalent to its predicate after the maximum number of times the device is reprocessed as intended by the person submitting the premarket notification.
On April 30, 2003 (68 FR 23139), as required by MDUFMA, FDA published two lists in the Federal Register: (1) A list of critical reprocessed SUDs whose exemption from 510(k) requirements will be terminated; and (2) a list of reprocessed SUDs that are currently subject to 510(k) requirements for which validation data must be submitted. FDA will update these lists as necessary.
The validation data required by MDUFMA must be submitted according to the following timetable:
- After publication of the lists manufacturers submitting new 510(k)s for listed devices must include validation data.
- Within 9 months after publication of the list (by January 30, 2004), manufacturers of listed devices with 510(k)s pending for these devices at the time the lists were published should either supplement these 510(k)s with validation data or resubmit them with validation data after clearance.
- Manufacturers of listed devices with 510(k)s for these devices cleared by FDA before publication of the lists must submit validation data for these devices within 9 months after publication of the lists (by January 30, 2004).
- Manufacturers of listed devices that were previously exempt from 510(k) submission requirements must submit validation data for these devices in 510(k) submissions within 15 months after publication of the lists (July 30, 2004).
- By April 26, 2004, FDA must publish a list of semi-critical reprocessed SUDs that will require the submission of validation data in 510(k) submissions. The publication of this list will trigger submission timeframes the same as those in the previous paragraphs.
Respondents to the proposed collection of information will likely be businesses or other for-profit organizations.
FDA estimates the burden of this information collection as follows:
|Item||No. of respondents||Annual rrequency per response||Total annual responses||Hours per response||Total hours|
|Submission of validation data (2003)||20||5||100||40||4,000|
|Submission of validation data (2004)||20||20||400||40||16,000|
|Submission of validation data (2005)||20||10||200||40||8,000|
|Start Printed Page 40678|
|1 There are no capital costs or operating and maintenance costs associated with this collection of information.|
Based on submissions received to date and registration and listing records for the affected devices, FDA estimates that there are 20 reprocessors of SUDs that will need to submit validation data. In calendar year 2003, FDA estimates that there will be 5 new 510(k)s for reprocessed SUDs. Based on its experience with reviewing 510(k)s and discussions with reprocessors, FDA estimates that it will take 40 hours per 510(k) to develop and submit the validation data. This results in a total burden of 4,000 for 2003. (In this estimate, FDA is only taking into account the burden related to validation data. The other collections of information related to the submission of information in a 510(k) have been approved by OMB in accordance with the PRA under the regulations governing premarket notification submissions (21 CFR part 807, subpart E, OMB control number 0910-0120).
In 2004, reprocessors with previously exempt and cleared devices will need to submit their validation data by January 30, 2004, and July 30, 2004. For 2004, FDA estimates that the 20 manufacturers will submit an average of 20 510(k)s each for a total burden of 16,000 hours.
In 2005, FDA estimates that the 20 manufacturers will submit 10 new 510(k)s each. This will result in a total burden of 8,000.Start Signature
Dated: July 1, 2003.
Assistant Commissioner for Policy.
[FR Doc. 03-17136 Filed 7-7-03; 8:45 am]
BILLING CODE 4160-01-S